Use of thrombopoietic growth factors in acute leukemia

Leukemia

Volumn 14, Issue 3, 2000, Pages 505-508

  Kaushansky, K ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Clinical trials; IL 11; MGDF; Thrombocytopenia; Thrombopoiesis; TPO

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 11; THROMBOPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DONOR; DRUG SAFETY; HUMAN; MEGAKARYOCYTE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0034096185     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401620     Document Type: Conference Paper

References (32)

1. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara Jr RM, Leary AC, Sibley B, Clark SC, Williams DA, Yang Y-C. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990; 87: 7512-7516.
2. Kaushansky K, Lok AS, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
3. de Sauvage FJ, Mass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
4. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, Zucker-Franklin D, Lofton-Day C. Thrombopoietin, the Mpl-ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995; 92: 3234-3238.
5. Nandurkar HH, Robb L, Tarlinton D, Barnett L, Köntgen F, Begley CG. Adult mice with targeted mutation of the interleukin-11 receptor (IL11R?) display normal hematopoiesis. Blood 1997; 90: 2148-2159.
6. Lok AS, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CD, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-568.
7. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
8. Sohma Y, Akahori H, Seki N, Hori T, Ogami K, Kato T, Shimada Y, Kawamura K, Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS 1994; 353: 57-61.
9. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and IL-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995; 85: 1719-1726.
10. Sitnicka E, Lin N, Priestley GV, Fox N, Broudy VC, Wolf NS, Kaushansky K. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 1996; 87: 4998-5005.
11. Alexander WS, Roberts AW, Nicola NA, Li R, Metcali D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996; 87: 2162-2170.
12. Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, Eaton DL. Role of c-mpl in early hematopoiesis. Blood 1998; 92: 4-10.
13. Souyri M, Vigon I, Penciolelli J-F, Tambourin P, Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137-1147.
14. Yan XQ, Lacey D, Hill D, Chen Y, Fletcher F, Hawley RG, McNiece IK. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood 1996; 88: 402-409.
15. Li Y, Hetet G, Kiladjian JJ, Gardin C, Grandchamp B, Briere J. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Br J Haematol 1996; 92: 60-66.
16. Matusmura I, Kanakura Y, Kato T, Ikeda H, Horikawa Y, Ishikawa J, Kitayama H, Nishiura T, Tomiyama Y, Miyazaki H, Matsuzawa Y. The biological properties of recombinant human thrombopoietin in the proliferation and rnegakaryocytic differentiation of acute myeloblastic leukemia cells. Blood 1996; 88: 3074-3082.
17. Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguie F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F. Prognostic value of c-mlp expression in myelodysplastic syndromes. Leukemia 1995; 9: 783-788.
18. Wetzler M, Baer MR, Bernstein SH, Blumenson L, Stewart C, Barcos M, Mrozek K, Block AW, Herzig GP, Bloomfield CD. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. J Clin Oncol 1997; 15: 2262-2268.
19. Leonard JP, Quinto CM, Kozitza MK, Neben TY, Goldman SJ. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994; 83: 1499-1506.
20. Grossmann A, Lenox J, Ren HP, Humes JM, Forstrom JW, Kaushansky K, Sprugel KH. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol 1996; 24: 1238-1246.
21. Fibbe WE, Heemskerk DP, Laterveer L, Pruijt JF, Foster D, Kaushansky K, Willemze R. Accelerated reconstitution of platelets and erythrocytes after syngenek transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995; 86: 3308-3313.
22. Molineaux G, Hartley C, McElroy P, McCrea C, McNiece IK. Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood 1996; 88: 366-376.
23. Molineaux G, Hartley CA, McElroy P, McCrea C, McNiece IK. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation. Blood 1996; 88: 1509-1514.
24. Neelis KJ, Dubbelman YD, Wognum AW, Thomas GR, Eaton DL, Egeland T, Wagemaker G. Lack of efficacy of thrombopoietin and granulocyte colony-stimulating factor after high-dose total body irradiation and autologous stem cell or bone marrow transplantation in rhesus monkeys. Exp Hematol 1997; 25: 1094-1103.
25. Tepler I, Elias L, Smith W, Hussein M, Rosen G, Chang AYC, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA. A randomized placebo-controlled trial of recombinant IL-11 in cancer patients with severe thrombocytopenia due to cancer. Blood 1996; 87: 3607-3614.
26. Fanucchi M, Glaspy J, Crawford J, Garst J, Figlin R, Sheridan W, Menchaca D, Tomita D, Ozer H, Harker L. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New Engl J Med 1997; 336: 404-409.
27. Basser RL, Rasko J, Clarke K, Cebon J, Green MD, Grigg A, Zalcberg J, Cohen B, O'Bryne J, Menchaca DM, Fox RM, Begley CG. Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filigrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 1997; 89: 3118-3128.
28. Vadhan-Raj S, Verschraegen C, McGarry L, Bueso-Ramos C, Kudelka A, Freedman R, Edwards C, Bevers M, Levenback C, Gershenson D, Jones D, Yang T, Bast RC, Kavanagh J. Recombinant human thrombopoietin (rhTPO) attenuates high-dose carboplatin (C)-induced thrombocytopenia in patients with gynecologic malignancy. Blood 1997; 90 (Suppl 1): 580a.
29. Bolwell B, Vredenburgh J, Overmoyer B, Gilbert C, Chap L, Menchaca D, Scarlata D, Glaspy J. Safety and biologic effect of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients following autologous peripheral blood progenitor cell transplantation (PBPC). Blood 1997; 90 (Suppl 1): 171a.
30. Somlo G, Sniecinski I, ter Veer A et al. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy. Blood 1999; 93: 2798-2806.
31. Archimbaud E, Ottmann O, Liu Yin JA, Lechner K, Dombret H, Sanz MA, Herrmann F, Gruss H, Fenaux P, Ganser A, Heil G, Kanz L, Brugger W, Sims T, Olsen K, Hoelzer D. A randomised, double-blind, placebo-controlled study using PEG-rHuMGDF as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia: early results. Blood 1996; 88 (Suppl 1): 447a.
32. Shibuya K, Akahori H, Takahashi K, Tahara E, Kato T, Miyazaki H. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood 1998; 91: 37-45.